The threat of vancomycin resistance

American Journal of Medicine

Volumn 106, Issue 5 A, 1999, Pages

  Perl, Trish M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; CONFERENCE PAPER; DISEASE TRANSMISSION; ENTEROCOCCUS; HOSPITAL INFECTION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SANITATION; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

EID: 0033519366     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00354-4     Document Type: Conference Paper

References (67)

1. Nosocomial enterococci resistant to vancomycin United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42:597-579.
2. Edmond M.B., Ober J.F., Dawson J.D., et al. Vancomycin-resistant enterococcal bacteremia natural history and attributable mortality . Clin Infect Dis. 23:1996;1234-1239.
3. Murray B.E. Vancomycin-resistant enterococci. Am J Med. 102:1997;284-293.
4. Noskin G.A. Vancomycin-resistant enterococci clinical, microbiologic, and epidemiologic features . J Lab Clin Med. 130:1997;14-20.
5. Palmer S.M., Rybak M.J. Vancomycin-resistant enterococci. Pharmacotherapy. 16:1996;819-829.
6. Fraimow H.S., Jungkind D.L., Lander D.W., et al. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med. 121:1994;22-26.
7. Fitzpatrick B, Harrington S, Smith D, et al. An outbreak of vancomycin dependent enterococci in an oncology center. Presented at 35th Annual Infectious Diseases Society of America Annual Meeting, September 13-16, 1997, San Francisco, CA.
8. Perl T.M., DeLisle S. The Emergence and Control of Vancomycin-resistant Enterococci. 1998;Scientific Exchange.
9. Loudon K., Burnie J.P. Is it time to stop searching for MRSA? Constant vigilance is needed to halt the emergence of resistance to vancomycin. BMJ. 315:1997;59.
10. Veach L.A., Pfaller M.A., Barret M., Koontz F.P., Wenzel R.P. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 28:1990;2064-2068.
11. Schwalbe R.S., Stapleton J.T., Gilligan P.H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 316:1987;927-931.
12. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46:765-766.
13. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46:813-815.
14. Smith T.L., Pearson M.L., Wilcox K.R., et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med. 340:1999;493-501.
15. Sierarzki K., Roberts R.B., Haber S.W., Tomasz A. The development of vancomycin resistance in a patient with methicillin-resisitant Staphyloccus aureus infection. N Engl J Med. 340:1999;517-523.
16. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep. 1997;46:626-628.
17. Witte W. Medical consequences of antibiotic use in agriculture. Science. 279:1998;996-997.
18. Ross T.W. Infectious disease challenge vancomycin-resistant enterococcus and staphylococcus . Drug Topics. 142:1998;76-83.
19. Bonafede M., Rice L.B. Emerging antibiotic resistance. J Lab Clin Med. 130:1997;558-566.
20. Murray B.E. Diversity among multidrug-resistant enterococci. Emerg Infect Dis. 4:1998;37-47.
21. Coque T.M., Tomayko J.F., Ricke S.C., et al. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 40:1996;2605-2609.
22. Woodford N., Chadwick P.R., Morrison D., Cookson B.D. Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak. J Clin Microbiol. 35:1997;2966-2968.
23. Archibald L., Phillips L., Monnet D., et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States increasing importance of the intensive care unit . Clin Infect Dis. 24:1997;211-215.
24. Jones R.N., Marshall S.A., Pfaller M.A., et al. Nosocomial enterococcal blood stream infections in the SCOPE program antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy . Diagn Microbiol Infect Dis. 29:1997;95-102.
25. Bonilla H.F., Zervos M.A., Lyons M.J., et al. Colonization with vancomycin-resistant Enterococcus faecium comparison of a long-term care unit with an acute-care hospital . Infect Control Hosp Epidemiol. 18:1997;333-339.
26. Henning K.J., Delencastre H., Eagan J., et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward duration of stool shedding and incidence of clinical infection . Pediatr Infect Dis J. 15:1996;848-854.
27. Nourse C., Murphy H., Byrne C., et al. Control of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric oncology unit risk factors for colonisation . Eur J Pediatr. 157:1998;20-27.
28. Shekar R., Chico G., Bass S.N., et al. Household transmission of vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 21:1995;1511.
29. Weber D.J., Rutala W.A. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 18:1997;306-309.
30. Noskin G.A., Stosor V., Cooper I., Peterson L.R. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol. 16:1995;577-581.
31. Bonilla H.F., Zervos M.J., Kauffman C.A. Long term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface. Infect Control Hosp Epidemiol. 17:1996;770-772.
32. Porwancher R., Sheth A., Remphrey S., et al. Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium possible transmission by an electronic ear-probe thermometer . Infect Control Hosp Epidemiol. 18:1997;771-772.
33. Bonten M.J., Hayden M.K., Nathan C., et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 348:1996;1615-1619.
34. Kirk M., Hill R.L.R., Casewell M.W., Beighton D. Isolation of vancomycin-resistant enterococci from supermarket poultry. Adv Exp Med Biol. 418:1997;289-291.
35. Van den Bogaard A.E., Jensen L.B., Stobberingh E.E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 337:1997;1558-1559.
36. Bates J., Jordens J.Z., Griffiths D.T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 34:1994;507-514.
37. Bates J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect. 37:1997;89-101.
38. Das I., Fraise A., Wise R. Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet. 349:1997;997-998.
39. Lai K.K., Fontecchio S.A., Kelley A.L. The epidemiology of fecal carriage of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 18:1997;762-765.
40. Roghmann M.C., Qaiyumi A., Schwalbe R., Morris J.G. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 18:1997;679-680.
41. Montecalvo M.A., Shay D.K., Gedris C., et al. A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci colonized patients pose an infection control risk . Clin Infect Dis. 25:1997;929-930.
42. Mainous M.R., Lipsett P.A., O'Brien M. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? Arch Surg. 132:1997;76-81.
43. Stroud L., Edwards J., Danzig L., et al. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol. 17:1996;576-580.
44. Papanicolaou G.A., Meyers B.R., Meyers J., et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients risk factors for acquisition and mortality . Clin Infect Dis. 23:1996;720-726.
45. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 16:1995;105-113.
46. Boyce J.M. Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am. 11:1997;367-384.
47. Boyce J.M., Mermel L.A., Zervos M.J., et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 16:1995;634-637.
48. Lorian V., Fernandes F. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol. 18:1997;678-679.
49. Saurina G., Landman D., Quale J.M. Activity of disinfectants against vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 18:1997;345-347.
50. Anderson R.L., Carr J.H., Bond W.W., Favero M.S. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol. 18:1997;195-199.
51. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria a report on the Rockefeller University workshop . N Engl J Med. 330:1994;1247-1251.
52. Ena J., Dick R.W., Jones R.N., Wenzel R.P. The epidemiology of intravenous vancomycin usage in a university hospital. JAMA. 269:1993;598-602.
53. Belliveau P.P., Rothman A.L., Maday C.E. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium. Am J Health-Syst Pharm. 53:1996;1570-1575.
54. Anglim A.M., Klym B., Byers K.E. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med. 157:1997;1132-1136.
55. Morgan A.S., Brennan P.J., Fishman N.O. Impact of a vancomycin restriction policy on use and cost of vancomycin-resistant Enterococcus. Ann Pharmacother. 31:1997;970-973.
56. Burke C.E., Piper J., Holloway W. Order form for restricting vancomycin prescribing. Am J Health-Syst Pharm. 54:1997;1893,1897.
57. Quale J., Landman D., Saurina G., et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 23:1996;1020-1025.
58. Quale J., Landman D., Atwood E., et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 24:1996;372-379.
59. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:624-626.
60. Hiramatsu K., Hanaki H., Ino T., et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [letter]. J Antimicrob Chemother. 40:1997;135-136.
61. Davidson H.E. New developments in Staphylococcus aureus resistance. Consul Pharm. 12:1997;1218-1219.
62. Ploy M.C., Grelaud C., Martin C. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital [letter; comment]. Lancet. 351:1998;1212.
63. Boyce J.M. Strategies for controlling methicillin-resistant Staphylococcus aureus in hospitals. J Chemother. 7:(suppl 3):1995;81-85.
64. Jernigan J.A., Titus M.G., Groschel D.H., et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 143:1996;496-504.
65. Edmond M.B., Wenzel R.P., Pasculle A.W. Vancomycin-resistant Staphylococcus aureus perspectives on mea-sures needed for control . Ann Intern Med. 124:1996;329-334.
66. Perl T.M., Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother. 32:(suppl):1998;S7-S16.
67. McDonald L.C., Kuehnert M.J., Tenover F.C., et al. Vancomycin-resistant enterococci outside the healthcare setting prevalence, sources, and public health implications . Emerg Infect Dis. 3:1997;311-315.